dor_id: 4119448
506.#.#.a: Público
590.#.#.d: Los artículos enviados a la revista "Contaduría y Administración", se juzgan por medio de un proceso de revisión por pares
510.0.#.a: Consejo Nacional de Ciencia y Tecnología (CONACyT); Sistema Regional de Información en Línea para Revistas Científicas de América Latina, el Caribe, España y Portugal (Latindex); Scientific Electronic Library Online (SciELO); SCOPUS, SCImago Journal Rank (SJR)
561.#.#.u: https://www.fca.unam.mx/
650.#.4.x: Ciencias Sociales y Económicas
336.#.#.b: article
336.#.#.3: Artículo de Investigación
336.#.#.a: Artículo
351.#.#.6: http://www.cya.unam.mx/index.php/cya/index
351.#.#.b: Contaduría y Administración
351.#.#.a: Artículos
harvesting_group: RevistasUNAM
270.1.#.p: Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx
590.#.#.c: Open Journal Systems (OJS)
270.#.#.d: MX
270.1.#.d: México
590.#.#.b: Concentrador
883.#.#.u: https://revistas.unam.mx/catalogo/
883.#.#.a: Revistas UNAM
590.#.#.a: Coordinación de Difusión Cultural
883.#.#.1: https://www.publicaciones.unam.mx/
883.#.#.q: Dirección General de Publicaciones y Fomento Editorial
850.#.#.a: Universidad Nacional Autónoma de México
856.4.0.u: http://www.cya.unam.mx/index.php/cya/article/view/577/575
100.1.#.a: Chukwuogor Ndu, Chiaku
524.#.#.a: Chukwuogor Ndu, Chiaku (2005). Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI). Contaduría y Administración; Núm. 217. Recuperado de https://repositorio.unam.mx/contenidos/4119448
245.1.0.a: Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI)
502.#.#.c: Universidad Nacional Autónoma de México
561.1.#.a: Facultad de Contaduría y Administración, UNAM
264.#.0.c: 2005
264.#.1.c: 2009-10-05
653.#.#.a: Financial performance; worst performing; profitability; return on equity; profit margin; correlation coefficient; expenditure; current ratio; liquidity; cash flow; coverage ratios; efficiency ratios; total asset turnover; solvency; research and development
506.1.#.a: La titularidad de los derechos patrimoniales de esta obra pertenece a las instituciones editoras. Su uso se rige por una licencia Creative Commons BY 4.0 Internacional, https://creativecommons.org/licenses/by/4.0/legalcode.es, fecha de asignación de la licencia 2009-10-05, para un uso diferente consultar al responsable jurídico del repositorio por medio del correo electrónico revista_cya@fca.unam.mx
884.#.#.k: http://www.cya.unam.mx/index.php/cya/article/view/577
001.#.#.#: oai:cya.www.revistas-conacyt.unam.mx:article/577
041.#.7.h: spa
520.3.#.a: This paper examines the financial performance of one of the 2002 worst performing company, protein design labs inc. For the period 1993 to 2002. Findings indicate that the profitability ratios such as return on equity, return on assets and net profit margin were negative for most of the years between 1993 and 2004. The pearson"s correlation coefficient between protein design"s net sales and r & d expenditure for the period 1993 to 2004 is .85 and is significant at 1 percent level. Between 1996 and 2004, annual expenditures on research and development exceeded the annual net sales. The current ratio of protein design ranges between 10:1 and 58:1 in 1998 and 2000 respectively. Protein design is by far more liquid than its competitors. The cash flow adequacy and cash interest coverage ratios indicate that protein design was extremely liquid for most of the period. Cash flows from financing were responsible for healthy cash flow situation. The efficiency ratios were poor. They show that during the period, protein design had the lowest total asset turnover when compared to its immediate competitors such as corixa and medummune. Despite poor earnings generating performance, protein design is among the top emerging pharmaceutical companies attracting high corporate alliances and investors" confidence. With a new chief executive, a new president of research and development, and a strong balance sheet, protein design labs inc is expecting greater profitability in the future
773.1.#.t: Contaduría y Administración; Núm. 217 (2005)
773.1.#.o: http://www.cya.unam.mx/index.php/cya/index
046.#.#.j: 2021-10-20 00:00:00.000000
022.#.#.a: ISSN electrónico: 2448-8410; ISSN impreso: 0186-1042
310.#.#.a: Trimestral
264.#.1.b: Facultad de Contaduría y Administración, UNAM
758.#.#.1: http://www.cya.unam.mx/index.php/cya/index
doi: https://doi.org/10.22201/fca.24488410e.2005.577
handle: 20bf51bfcca7ab4f
harvesting_date: 2021-06-14 11:43:00.0
245.1.0.b: Factors contributing to the categorization of worst performing companies. the case of protein sesign labs, inc. (pdli)
last_modified: 2023-03-22 16:00:00
license_url: https://creativecommons.org/licenses/by/4.0/legalcode.es
license_type: by
No entro en nada
No entro en nada 2